Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Pediatric Loss-of-Control Eating and Anxiety in Relation to Components of Metabolic Syndrome.

Byrne ME, Tanofsky-Kraff M, Kelly NM, Grammer AC, Jaramillo M, Mi SJ, Stojek MM, Shank LM, Burke NL, Cassidy O, Schvey NA, Brady SM, Demidowich AP, Broadney MM, Yanovski SZ, Yanovski JA.

J Pediatr Psychol. 2019 Mar 1;44(2):220-228. doi: 10.1093/jpepsy/jsy077.

PMID:
30339233
2.

Short-term and long-term effects of caesarean section on the health of women and children.

Sandall J, Tribe RM, Avery L, Mola G, Visser GH, Homer CS, Gibbons D, Kelly NM, Kennedy HP, Kidanto H, Taylor P, Temmerman M.

Lancet. 2018 Oct 13;392(10155):1349-1357. doi: 10.1016/S0140-6736(18)31930-5. Review.

PMID:
30322585
3.

Parturition and the perinatal period: can mode of delivery impact on the future health of the neonate?

Tribe RM, Taylor PD, Kelly NM, Rees D, Sandall J, Kennedy HP.

J Physiol. 2018 Dec;596(23):5709-5722. doi: 10.1113/JP275429. Epub 2018 Apr 15.

PMID:
29533463
4.

Can community structure track sea-level rise? Stress and competitive controls in tidal wetlands.

Schile LM, Callaway JC, Suding KN, Kelly NM.

Ecol Evol. 2017 Jan 27;7(4):1276-1285. doi: 10.1002/ece3.2758. eCollection 2017 Feb.

5.

Does food vendor density mediate the association between neighborhood deprivation and BMI?: a G-computation mediation analysis.

Zhang YT, Laraia BA, Mujahid MS, Tamayo A, Blanchard SD, Warton EM, Kelly NM, Moffet HH, Schillinger D, Adler N, Karter AJ.

Epidemiology. 2015 May;26(3):344-52. doi: 10.1097/EDE.0000000000000271.

6.

Synthesis and biological evaluation of Esaprazole analogues showing σ1 binding and neuroprotective properties in vitro.

Kelly NM, Wellejus A, Elbrønd-Bek H, Weidner MS, Jørgensen SH.

Bioorg Med Chem. 2013 Jun 1;21(11):3334-47. doi: 10.1016/j.bmc.2013.02.058. Epub 2013 Apr 2.

PMID:
23601816
7.
8.

4-iodophenyl isothiocyanate: a neuroprotective compound.

Wellejus A, Elbrønd-Bek H, Kelly NM, Weidner MS, Jørgensen SH.

Restor Neurol Neurosci. 2012;30(1):21-38. doi: 10.3233/RNN-2011-0617.

PMID:
22082767
9.

2-(Cyclohexylamino)-1-(4-cyclopentylpiperazin-1-yl)-2-methylpropan-1-one, a novel compound with neuroprotective and neurotrophic effects in vitro.

Elbrønd-Bek H, Wellejus A, Kelly NM, Weidner MS, Jørgensen SH.

Neurochem Int. 2011 Nov;59(6):821-9. doi: 10.1016/j.neuint.2011.08.003. Epub 2011 Aug 9.

PMID:
21854820
10.

Photobleaching kinetics of Verteporfin and Lemuteporfin in cells and optically trapped multilamellar vesicles using two-photon excitation.

Tekrony AD, Kelly NM, Fage BA, Cramb DT.

Photochem Photobiol. 2011 Jul-Aug;87(4):853-61. doi: 10.1111/j.1751-1097.2011.00933.x. Epub 2011 May 10.

PMID:
21488879
11.

Is the 'driving test' a robust quality indicator of colonoscopy performance?

Kelly NM, Moorehead J, Tham T.

World J Gastrointest Endosc. 2010 Apr 16;2(4):112-20. doi: 10.4253/wjge.v2.i4.112.

12.

In situ immobilization of palladium nanoparticles in microfluidic reactors and assessment of their catalytic activity.

Lin R, Freemantle RG, Kelly NM, Fielitz TR, Obare SO, Ofoli RY.

Nanotechnology. 2010 Aug 13;21(32):325605. doi: 10.1088/0957-4484/21/32/325605. Epub 2010 Jul 21.

PMID:
20647623
13.

Discovery of selective nonpeptidergic neuropeptide FF2 receptor agonists.

Gaubert G, Bertozzi F, Kelly NM, Pawlas J, Scully AL, Nash NR, Gardell LR, Lameh J, Olsson R.

J Med Chem. 2009 Nov 12;52(21):6511-4. doi: 10.1021/jm9011998.

PMID:
19803524
14.

Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis.

Malik L, Kelly NM, Ma JN, Currier EA, Burstein ES, Olsson R.

Bioorg Med Chem Lett. 2009 Mar 15;19(6):1729-32. doi: 10.1016/j.bmcl.2009.01.085. Epub 2009 Jan 30.

PMID:
19230660
15.

Understanding large-scale deforestation in southern Jinotega, Nicaragua from 1978 to 1999 through the examination of changes in land use and land cover.

Zeledon EB, Kelly NM.

J Environ Manage. 2009 Jul;90(9):2866-72. doi: 10.1016/j.jenvman.2008.03.016. Epub 2008 Oct 22.

PMID:
18947917
16.
17.

Temporal and spatial relationships between watershed land use and salt marsh disturbance in a pacific estuary.

Byrd KB, Kelly NM, Merenlender AM.

Environ Manage. 2007 Jan;39(1):98-112. Epub 2006 Nov 14.

PMID:
17106797
18.

Photobleaching kinetics of optically trapped multilamellar vesicles containing verteporfin using two-photon excitation section sign.

Samkoe KS, Fecica MS, Goyan RL, Buchholz JL, Campbell C, Kelly NM, Cramb DT.

Photochem Photobiol. 2006 Jan-Feb;82(1):152-7.

PMID:
16149861
19.
20.

Antiendotoxin activity of cationic peptide antimicrobial agents.

Gough M, Hancock RE, Kelly NM.

Infect Immun. 1996 Dec;64(12):4922-7.

21.

A differential response to treatment with divalproex sodium in patients with intractable headache.

Rothrock JF, Kelly NM, Brody ML, Golbeck A.

Cephalalgia. 1994 Jun;14(3):241-4.

PMID:
7954747
22.

Interleukin-6 is a better marker of lethality than tumor necrosis factor in endotoxin treated mice.

Kelly NM, Cross AS.

FEMS Microbiol Immunol. 1992 Aug;4(6):317-22.

PMID:
1524837
23.
24.

Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.

Opal SM, Cross AS, Sadoff JC, Collins HH, Kelly NM, Victor GH, Palardy JE, Bodmer MW.

J Clin Invest. 1991 Sep;88(3):885-90.

25.

Bacteria-phagocyte interactions: emerging tactics in an ancient rivalry.

Cross AS, Kelly NM.

FEMS Microbiol Immunol. 1990 Dec;2(5-6):245-58. Review.

PMID:
2073407
26.

Comparison of the outer membrane protein and lipopolysaccharide profiles of mucoid and nonmucoid Pseudomonas aeruginosa.

Kelly NM, MacDonald MH, Martin N, Nicas T, Hancock RE.

J Clin Microbiol. 1990 Sep;28(9):2017-21.

27.

Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa.

Opal SM, Cross AS, Kelly NM, Sadoff JC, Bodmer MW, Palardy JE, Victor GH.

J Infect Dis. 1990 Jun;161(6):1148-52.

PMID:
2140582
28.

Pseudomonas aeruginosa pili as ligands for nonopsonic phagocytosis by fibronectin-stimulated macrophages.

Kelly NM, Kluftinger JL, Pasloske BL, Paranchych W, Hancock RE.

Infect Immun. 1989 Dec;57(12):3841-5.

29.

Fibronectin as an enhancer of nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages.

Kluftinger JL, Kelly NM, Jost BH, Hancock RE.

Infect Immun. 1989 Sep;57(9):2782-5.

31.

Stimulation by fibronectin of macrophage-mediated phagocytosis of Pseudomonas aeruginosa.

Kluftinger JL, Kelly NM, Hancock RE.

Infect Immun. 1989 Mar;57(3):817-22.

32.
33.

Colonial dissociation and susceptibility to phagocytosis of Pseudomonas aeruginosa grown in a chamber implant model in mice.

Kelly NM, Battershill JL, Kuo S, Arbuthnott JP, Hancock RE.

Infect Immun. 1987 Nov;55(11):2841-3.

34.

Mucoid gram-negative bacilli in cystic fibrosis.

Kelly NM, Falkiner FR, Keane CT, Fitzgerald MX, Tempany E.

Lancet. 1983 Mar 26;1(8326 Pt 1):705. No abstract available.

PMID:
6132059
35.

Acetamide broth for isolation of Pseudomonas aeruginosa from patients with cystic fibrosis.

Kelly NM, Falkiner FR, Keane CT.

J Clin Microbiol. 1983 Jan;17(1):159.

36.

Does pseudomonas cross-infection occur between cystic-fibrosis patients.

Kelly NM, Fitzgerald MX, Tempany E, O'Boyle C, Falkiner FR, Keane CT.

Lancet. 1982 Sep 25;2(8300):688-90.

PMID:
6126629
37.

Health education through entertainment: a multimedia campaign.

Kelly NM.

J Am Coll Health Assoc. 1978 Apr;26(5):248-52. No abstract available.

PMID:
78936

Supplemental Content

Loading ...
Support Center